Skip to Main Content

Paper Details

Reply to comments on: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients.
ESMO Open
1
2022
  • 1 - 1

Datasets